These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


448 related items for PubMed ID: 19173882

  • 1. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX, Dang RB, Zhang WD, Liang XF, Cui FQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [Abstract] [Full Text] [Related]

  • 2. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY, Gong YL, Yu SL, Shao RT, Qin HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [Abstract] [Full Text] [Related]

  • 3. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF, Chen TH.
    Vaccine; 2009 Nov 12; 27(48):6770-6. PubMed ID: 19735755
    [Abstract] [Full Text] [Related]

  • 4. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2005 May 12; 36(3):693-9. PubMed ID: 16124440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City].
    Liu ZG, Zhao SL, Zhang YX.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr 12; 16(2):81-4. PubMed ID: 7781052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
    Zhang SX.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May 12; 26(3):154-8. PubMed ID: 1395956
    [Abstract] [Full Text] [Related]

  • 9. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ, Cowper PA, Hamilton JD, Feussner JR.
    Health Serv Res; 1993 Apr 12; 28(1):97-121. PubMed ID: 8463111
    [Abstract] [Full Text] [Related]

  • 10. [Forecasting strategies of hepatitis B vaccination based on decision tree model].
    Zhang SX.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug 12; 10(4):193-7. PubMed ID: 2509074
    [Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY, Billah K, Lieu TA, Weinstein MC.
    Am J Prev Med; 2006 Jun 12; 30(6):498-506. PubMed ID: 16704944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.
    Arch Pediatr Adolesc Med; 2005 Dec 12; 159(12):1136-44. PubMed ID: 16330737
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK, Hutton G, Das Dores Pascoal E.
    Health Policy Plan; 2005 Jan 12; 20(1):50-9. PubMed ID: 15689430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.